Hennion & Walsh Asset Management, Inc.
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1861642
Parsippany, NJ
Position in JAZZ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$11,571,138
+$2,241,143 QoQ
Shares Held
48,019
-2.7% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#119
of 640 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. JAZZ ranks #1 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in JAZZ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,571,138 | 48,019 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $9,329,995 | 49,352 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,080,950 | 47,535 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,992,320 | 37,878 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,914,979 | 36,892 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,693,118 | 37,802 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,420,346 | 35,894 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,516,322 | 31,562 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,142,878 | 29,447 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,042,290 | 25,264 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,560,737 | 20,819 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,996,612 | 15,425 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,514,541 | 12,217 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,358,235 | 9,282 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,366,879 | 8,580 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $857,187 | 6,431 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $872,095 | 5,590 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $765,740 | 4,919 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $653,179 | 5,127 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $841,417 | 6,462 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,188,233 | 6,689 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,143,193 | 6,955 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||